Thomson Medical Group Limited

A50.SI : Singapore Exchange



Share Price in SGD. As of 17 Jul 17:14:06 SGT



Key stats

  • 52-Week High
    SGD 0.063
  • 52-Week Low
    SGD 0.049
  • Market Cap
    SGD 1.3B
  • Avg Volume
  • P/E Ratio (TTM)
  • Forward Dividend Yield

Share Price Performance

1 Day 2.04% 0.01%
5 Day 0.00% 0.42%
1 Month 0.00% 4.37%
6 Month -5.66% 11.05%
YTD -18.03% 8.04%
1 Year -12.28% 8.46%
5 Year -10.71% 11.85%
Include dividend return
Market Analysis

Analyst Ratings

  • Maybank Research

    27 Feb 2024




Price to earnings (P/E) ratio

Current P/E
Historical Average P/E

Thomson Medical Group Limited's current P/E ratio of ∞x is inline with its historical average P/E ratio of NaNx.

Price to book (P/B) ratio

Current P/B
Historical Average P/B

Thomson Medical Group Limited's current P/B ratio of 2.8x is inline with its historical average P/B ratio of 2.8x.


Earnings per share (EPS)

The latest earnings per share is $0.00, which is inline with the earnings per share of $0.00 in 2022.


Financial Statements

07 Feb 2024

Half Yearly Results

For period ending 31 Dec 2023

28 Aug 2023

Full Yearly Results

For period ending 30 Jun 2023

Annual Reports

22 Sep 2023

Annual Report

For period ending 30 Jun 2023


Company Description

Listed on the Mainboard of the Singapore Exchange, Thomson Medical Group Limited (SGX: A50) is one of the leading listed healthcare players in the South-East Asian region with operations in Singapore and Malaysia. Established in 1979, the Group’s Thomson Medical Pte Ltd is one of the largest private provider of healthcare services for women and children in Singapore. It owns and operates the iconic Thomson Medical Centre and a network of specialist medical clinics and facilities providing outpatient women and children healthcare services and service offerings in diagnostic imaging, health screening, gynaecological oncology, dentistry, specialist dermatology, traditional Chinese medicine, musculoskeletal and sports medicine, and medical aesthetics. The Group's operations in Malaysia under TMC Life Sciences Berhad is a multi-disciplinary healthcare company listed on Bursa Malaysia. It operates Thomson Hospital Kota Damansara, a tertiary hospital located in Kota Damansara, and the award-winning TMC Fertility Centre which is the industry leader in assisted reproduction in Malaysia. It also owns the proposed Thomson Iskandar Medical Hub, in Johor Bahru, Malaysia. The Group also owns a prime 9.23 ha freehold waterfront land, strategically located in Johor Bahru’s City Centre, with a proposed long term plan to build an integrated healthcare city to meet the growing healthcare needs of the people in the region.


Hot stocks that may interest you